ArticleFrontiers in oncology2019

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.

Marco La Ferla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.